Updated clinical data from the squamous cell carcinoma of the head and neck (SCCHN) expansion cohort of an ongoing Ph1/1b study of eganelisib (formerly IPI-549) in combination with nivolumab Meeting Abstract


Authors: Cohen, E.; Postow, M.; Sullivan, R.; Hong, D.; Yeckes-Rodin, H.; McCarter, J.; Zizlsperger, N.; Kutok, J.; O'Connell, B.; Page, K.; Roberts, J.; Zhang, H.; Chmielowski, B.
Abstract Title: Updated clinical data from the squamous cell carcinoma of the head and neck (SCCHN) expansion cohort of an ongoing Ph1/1b study of eganelisib (formerly IPI-549) in combination with nivolumab
Meeting Title: 35th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
Journal Title: Journal for ImmunoTherapy of Cancer
Volume: 8
Issue: Suppl. 3
Meeting Dates: 2020 Nov 9-14
Meeting Location: Virtual
ISSN: 2051-1426
Publisher: Biomed Central Ltd  
Date Published: 2020-10-01
Start Page: A214
End Page: A215
Language: English
ACCESSION: WOS:000616665300341
DOI: 10.1136/jitc-2020-SITC2020.0352
PROVIDER: wos
Notes: Meeting Abstract: 352 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Michael Andrew Postow
    365 Postow